10 March 2008 in QJM: An International Journal of Medicine
Dual-energy X-ray absorptiometry (DXA) is recognized as the reference method to measure bone mineral density (BMD) with acceptable accuracy errors and good precision and reproducibility. The World Health Organization (WHO) has established DXA as the best densitometric technique for assessing BMD in postmenopausal women and based the definitions of osteopenia and osteoporosis on its results. DXA allows accurate diagnosis of osteoporosis, estimation of fracture risk and monitoring of patients undergoing treatment. However, when DXA studies are performed incorrectly, it can lead to major mistakes in diagnosis and therapy. This article reviews the fundamentals of positioning, scan analysis and interpretation of DXA in clinical practice.
1 December 2011 in European Journal of Internal Medicine
22 October 2013 in Osteoporosis International
FDfor the International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease
for the International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer-Induced Bone Disease
+10
1 August 2001 in Osteoporosis International
1 July 2004 in Joint Bone Spine